Kaplan–Meier survival analysis showed that HCC patients with reduced PFDN6L expression exhibited significantly shorter overall survival than those with higher tumor expression levels (Fig. 1D) (p < 0.001). Here, CCDC30 is linked to hepatocellular carcinoma.